EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Treatment of [ 99mTc ]Tc‐hydroxy‐diphosphonate ([ 99mTc ]Tc‐ HDP ) extravasation using hyaluronidase

Kevin R Doornhof iD, Quido de Lussanet de la Sablonière iD, Stijn L W Koolen iD, Mark W Konijnenberg iD

Pharmacology Research & Perspectives · 2024

DOI: 10.1002/prp2.1232 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Pharmacology Research & Perspectives, 2024. Verfasst von Kevin R Doornhof und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology and Nuclear Medicine, Erasmus Medical Center, University Medical Center Rotterdam, Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Extravasation of Diagnostic and Therapeutic Materials, Hyaluronoglucosaminidase, Radiopharmaceuticals. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extravasation of 99mTc‐labeled radiopharmaceuticals is generally considered to require no specific intervention. In the presented case, the use of hyaluronidase could have minimized the adverse effects resulting from such an extravasation. Currently, no guidelines exist regarding the use of hyaluronidase after extravasation of [99mTc]Tc‐HDP. Considering the low risk of administering hyaluronidase, it should be considered to limit the risk of injury after extravasation of [99mTc]Tc‐HDP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extravasation of Diagnostic and Therapeutic MaterialsHyaluronoglucosaminidaseRadiopharmaceuticalsHumansOrganotechnetium CompoundsTechnetium Tc 99m Medronate

Stichwörter der Autor:innen

bone scintigraphyextravasationradiology [99mTc]Tc‐HDP

Substanzen

HyaluronoglucosaminidaseOrganotechnetium CompoundsRadiopharmaceuticalstechnetium Tc 99m hydroxymethylene diphosphonateTechnetium Tc 99m Medronate

Autor:innen und Institutionen

  • Department of Radiology and Nuclear Medicine, Erasmus Medical Center, University Medical Center Rotterdam, Rotterdam, The Netherlands.

ORCID-Profile: Kevin R Doornhof, Quido de Lussanet de la Sablonière, Stijn L W Koolen, Mark W Konijnenberg

Zitieren

APA

Doornhof, K. R., de Lussanet de la Sablonière, Q., Koolen, S. L. W., & Konijnenberg, M. W. (2024). Treatment of [ 99mTc ]Tc‐hydroxy‐diphosphonate ([ 99mTc ]Tc‐ HDP ) extravasation using hyaluronidase. Pharmacology Research & Perspectives. https://doi.org/10.1002/prp2.1232

Vancouver

Doornhof KR, de Lussanet de la Sablonière Q, Koolen SLW, Konijnenberg MW. Treatment of [ 99mTc ]Tc‐hydroxy‐diphosphonate ([ 99mTc ]Tc‐ HDP ) extravasation using hyaluronidase. Pharmacology Research & Perspectives. 2024. doi:10.1002/prp2.1232

BibTeX
@article{Doornhof2024,
  author = {Doornhof, Kevin R and de Lussanet de la Sablonière, Quido and Koolen, Stijn L W and Konijnenberg, Mark W},
  title = {Treatment of [ 99mTc ]Tc‐hydroxy‐diphosphonate ([ 99mTc ]Tc‐ HDP ) extravasation using hyaluronidase},
  journal = {Pharmacology Research & Perspectives},
  year = {2024},
  doi = {10.1002/prp2.1232}
}
Kostenlos starten →